Search
for
Sort by
Research 331–360 of 1000+
- Antiaging effects of equol: A unique antiandrogenic isoflavone metabolite and its influence in stimulating collagen deposition in human dermal monolayer fibroblasts
- Frontal Fibrosing Alopecia and Reproductive Health: Assessing the Role of Sex Hormones in Disease Development
- The SAHA Syndrome
- Iatrogenic cushing’s syndrome post intralesional triamcinolone acetonide in oral submucous fibrosis: 2 case reports
- O-11 DIAGNOSTIC CHALLENGES IN POSTMENOPAUSAL HYPERANDROGENISM: REPORTS OF TWO CASES
- Dermatological Findings among Infertile Females in Duhok City, Iraq (2023)
- Secondary Amenorrhea and Clinical Hyperandrogenism in a 34-Year-Old Female: Polycystic Ovary Syndrome or Not?
- P-12 ACTH-INDEPENDENT CUSHING SYNDROME WITH INCONCLUSIVE ADRENAL CT SCAN RESULTS
- 8162 A Unique Presentation of Ovarian Steroid Cell Tumor Causing Hyperandrogenism in a Postmenopausal Woman
- Minoxidil oral en alopecias no androgénicas
- Dermatological considerations for transgender and gender diverse patients: An Australian perspective
- METYRAPONE AS A BRIDGING THERAPY IN FLORID CUSHING’S DISEASE PATIENT PRIOR TO PITUITARY ADENOMECTOMY
- Evaluation of Serum Testosterone, Cholesterol and Plasma Glucose Concentrations in Hirsute Women in Bayelsa State
- Ex-Vivo Evaluation of Eflornitine Hydrochloride Loaded Solid Lipid Microparticles Based Cream
- MON-024 Steroid Cell Tumor, Not Otherwise Specified; A Rare Case of Hyperandrogenism
- SAT-293 Novel Presentation Of A Heterozygous INSR Mutation And Markedly Elevated Testosterone Levels In A Pediatric Patient, A Case Report.
- Viva questions from the IJDVL
- Συχνότητα και μελέτη του δασυτριχισμού στον ελληνικό πληθυσμό
- Treatment options for polycystic ovary syndrome
- Safety of testosterone treatment in postmenopausal women
- Cutaneous manifestations of polycystic ovary syndrome: A cross-sectional clinical study
- Polycystic ovary syndrome
- A Review of the Most Common Dermatologic Conditions and their Debilitating Psychosocial Impacts
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- The impact of obesity on the folliculosebaceous unit
- Patient characteristics associated with symptoms of anxiety, depression, and reduced body appreciation in women with polycystic ovary syndrome
- Polycystic ovary syndrome: pragmatic management across levels of care
- Polycystic ovary syndrome
- Sexual Hormones in Human Skin